According to Privett:

"I've been practicing law for over 35 years. This gives me the ability to make decisions based on experience and sound reasoning being seasoned in trial combat." 

Defective Baxter Colleague Infusion Pump Lawyers Fighting for Injured Patients


When people who are struggling with sometimes severe health problems have an ongoing need for the delivery of nutrients and medication to help them survive, the use of different types of pumps have provided them with an automated delivery system in recent years. These pumps were supposed to deliver these critical substances to patients in a regular and controlled manner that would eliminate the possibility of human error. Unfortunately, many of these pump products have resulted in more harm done to patients than good.


One of the leading product lines within this market is known as the Baxter Colleague Infusion pump line, and these products have been under intense scrutiny for years, culminating in the recent FDA order to recall them from the United States market. Below you’ll find information regarding a basic description of these products, the problems that arose with them, estimates regarding the number of people who have been harmed by them, the FDA’s dealings with the manufacturer and finally how you should proceed if you or someone you love needs the help of a defective medical device lawyer.


Baxter Colleague Infusion Pumps – A Brief Overview


Baxter Colleague Infusion pumps have been on the market for more than a decade, and they are manufactured and controlled by two separate entities in the United States – Baxter International, the corporate umbrella of a series of subsidiaries, and the Baxter Healthcare Corporation, which is the American subsidiary of the larger entity.


These Baxter Colleague Infusion pumps were designed to perform as described above – to provide patients with regular, controlled and ongoing doses of necessary nutritional substances and medication to patients who needed it regularly and who were generally unable to handle the administration of these substances by themselves. While the theory behind these products was seen as innovative, the execution of the idea has led to seemingly constant problems and led to an enormous amount of harm to unsuspecting patients.


The Problems with and Fallout from Baxter Colleague Infusion Pumps


Unfortunately for thousands of people, there have been regular reports of serious problems with these Baxter Colleague Infusion pumps. Specifically, these problems included:


  • Battery malfunctions
  • Electrical malfunctions
  • Software malfunctions
  • User interface problems
  • A tendency to overheat, leading to smoke and fire


Perhaps even more severe than the defects listed above is the result of any of them – an interruption in the delivery of the substances that were critical for the viability of the patient. Since these pumps were designed to allow for a minimization of human oversight, many of these malfunctions led to prolonged periods of a lack of delivery of the substances, creating immediate and severe danger for the patients.


As a result of using these defective Baxter Colleague Infusion pumps, there were approximately 56,000 adverse effects reports generated across the country, and more than 500 deaths have been linked to the use of these defective models. In addition to those who have already suffered, there have also been approximately 200,000 units of these products that remained in use in the United States despite the fact that no new models have been manufactured since 2005.


Defective Baxter Colleague Infusion Pumps and the FDA


The history between the manufacturers of these defective Baxter Colleague Infusion pumps and the FDA dates back as far as 1999. Over the years, the FDA has enforced several regulations against the company, and including the latest order for a recall, there have now been three Class I recalls of these types of products manufactured by Baxter. The previous recalls occurred in 2005 and in 2009, and a Class I recall is considered to present the most danger to the public.


Most recently, Baxter and the FDA had been negotiating regarding the proposed steps Baxter would take to make the necessary repairs and adjustments to these products in order to minimize the dangers that already existed. In their last proposal, Baxter offered to initiate these repairs in 2012 and to complete them by 2013. The FDA saw this offer as unacceptable and has ordered a recall of models named Mono, CX & CXE, effective immediately.


How a Baxter Colleague Infusion Pump Recall Lawyer Can Help


While this somewhat rare step by the FDA of ordering a recall will likely protect many patients going forward, it does nothing to address the massive amount of harm that’s already been done to so many people who needed help and did not receive it from these defective Baxter Colleague Infusion pumps.


Therefore, if you or someone you love has been harmed as a result of depending on these products, you need to take action to protect your legal rights. Privett Law has been successful holding defendants who created this level of harm accountable for many years, so contact the firm today to schedule a free initial consultation.